Axsome Therapeutics (AXSM) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to -$23.3 million.
- Axsome Therapeutics' Other Gross PP&E Adjustments fell 21703.69% to -$23.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.3 million, marking a year-over-year decrease of 21703.69%. This contributed to the annual value of -$5.4 million for FY2024, which is 2051.09% up from last year.
- Per Axsome Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$23.3 million for Q3 2025, which was down 21703.69% from -$25.7 million recorded in Q2 2025.
- Axsome Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at -$384568.0 during Q3 2022, with a 5-year trough of -$28.1 million in Q1 2025.
- In the last 4 years, Axsome Therapeutics' Other Gross PP&E Adjustments had a median value of -$7.3 million in 2024 and averaged -$9.7 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first plummeted by 215577.79% in 2023, then skyrocketed by 2051.09% in 2024.
- Quarter analysis of 4 years shows Axsome Therapeutics' Other Gross PP&E Adjustments stood at -$420000.0 in 2022, then crashed by 1512.38% to -$6.8 million in 2023, then grew by 20.51% to -$5.4 million in 2024, then tumbled by 332.12% to -$23.3 million in 2025.
- Its Other Gross PP&E Adjustments was -$23.3 million in Q3 2025, compared to -$25.7 million in Q2 2025 and -$28.1 million in Q1 2025.